Suven Life Sciences has entered into a ‘stalking-horse’ asset purchase agreement to buy the assets of Aceto Corporation’s Rising Pharmaceuticals and rising subsidiaries through its joint venture partner Shore Suven Pharma, Inc., subject to Court-approved bidding process of US Bankruptcy Code.
Shore Suven Pharma, Inc. is a joint venture between Suven Life Sciences and Shore Pharma Investments, LLC of USA.
Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.
